A glance at today's headlines on the Proactive newswire ...
Showing 16 of 2088
Elsewhere, Asiamet Resources raises £2mln; Berkeley Energia adds another piece to the Salmanca puzzle; Tissue Regenix opens another door in the US; plus much more…
Elsewhere, Haydale Graphene agrees a development deal with Araldite maker; Akers Biosciences hails its “highly successful” diabetes trial; Tissue Regenix signs it first European distribution agreements; plus much more…
Immupharma among the small cap pharmas in focus on Wednesday, alongside Futura Medical, Horizon Discovery Group, and Summit Therapeutics.
Miners provided the day's highlights, but they weren't alone.
Elsewhere, Akers Biosciences has secured a European patent; CloudTag makes progress on recent order; takeover sharks are circling ServicePower; plus much more…
Also covered: Armadale Capital, CloudTag, Ceres Power, European Metals, Gfinity, Kromek, Metal Tiger, Rare Earth Minerals, Savannah Resources, San Leon Energy, Telit, Venn Life
BATM secures a contract down under; Victoria Oil & Gas starts development drilling in Cameroon; Allergy Therapeutics secures European patent; plus much more
On the day Misys called off its planned flotation, Futura and Strategic Minerals found willing buyers for their shares.
Suddenly there’s cash swilling around the AIM natural resources sector, but the return of positive sentiment is too little too late for Xcite Energy.
Sareum, Faron, WideCells, Abzena and Ergomed were among Monday's small cap highlights
Britain's onshore oil and gas sector was a focus for investors on Monday.
As our mining expert Alastair Ford pointed out, its been a long hiatus with no corporate activity of any real significance at the junior level for nearly seven years, but deals are now popping up.
Wednesday's small cap news highlights from Proactive Investors.
US markets were closed on Monday for the Labor Day holiday. US markets resume trading on Tuesday, September 6 when our coverage returns.
Wall Street shares held onto gains on Friday, after high dividend payers drove gains and low non-farm payrolls pointed to a possible delay in hiking US interest rates